In an intriguing deal, GE Medical Systems, one of the largest suppliers of MRI and PET equipment, is teaming up with Genometrix, Inc., an applied genomics company in a research collaboration that will combine molecular imaging techniques with genetic probes to develop technologies for detecting and quantifying risk levels for diseases such as breast and prostate cancer.
While the field of genomics has exploded loudly, another area of medical research, molecular imaging, has also evolved, albeit much more sotto voce. And while it perhaps won't have as great an impact on medicine as genomics, it too has the potential to contribute much, particularly as it uses discoveries and tools stemming from genomics work.
The National Cancer Institute and academic scientists have plunged into research merging the two, but industry has moved slowly....
Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.
Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.
